Posts
- Category: organization (continued)
- Research4HD.org founded on May 15, 2012 relaunched October 25, 2012: The first website for direct donations to Huntington’s disease Researchers, Foundations and Clinics.
- Reshaping my career and life in the face of Huntington’s disease (and a note of hope)
- Results of Auspex Pharmaceuticals' Phase 3 Registration Trial of SD-809 to be Presented at AAN Annual Meeting
- Ricerca, cura e assistenza nella Malattia di Huntington: ultimi risultati raggiunti
- Social Security Commissioner, Michael J. Astrue, announced today that the SSA is adding Juvenile Onset HD (JHD) as a Compassionate Allowance (CAL) condition!
- SPECIALE TERAPIA GENICA
- Stem Cell Agency Commits $150 Million To Develop New Therapies
- Strangling of patient in nursing home a shuddering reminder of subpar care for Huntington’s disease
- Surprising Discovery: Brain Variants of Protein Associated with Huntington's and Other Neurodegenerative Diseases Identified
- Talking as a family about HD
- The end of fear and exclusion: informing my health insurance plan about the risk of Huntington’s disease
- The Faces of Huntington's Disease - July 2012
- The Faces of Huntington's Disease The Huntington's Disease Project Magazine!
- The HD Community is Not Ignorant!
- The Huntington's Disease Project - 2012 Trailer (Italian Version)
- The precious participation of the Huntington’s disease community in the quest for treatments: a report on the 2015 HD Therapeutics Conference
- To take, or not to take, unproven supplements in the fight against Huntington’s disease
- Uguale, ma molto diversa: la Malattia di Huntington Giovanile
- Yale’s partnership against Huntington’s disease: an alumnus reconnects and finds hope as scientists pursue ‘Viagra for the brain’ and other solutions
- ‘Darkness replaced by hope and light’: taking stock of Huntington’s disease research
- ‘It’s really getting real’: payoffs in the effort to treat Huntington’s disease
- ‘None of us are free until we are all free’: science and solidarity at the 10th Annual Huntington’s Disease Therapeutics Conference
- Category: Scientific Articles Free
- A Brief Prehistory of Huntington's Disease
- A Genome-Scale RNA–Interference Screen Identifies RRAS Signaling as a Pathologic Feature of Huntington's Disease
- A Genome-Scale RNA–Interference Screen Identifies RRAS Signaling as a Pathologic Feature of Huntington's Disease
- A Huntingtin Peptide Inhibits PolyQ-Huntingtin Associated Defects
- A Large-scale Huntingtin Protein Interaction Network Implicates Rho GTPase Signaling Pathways in Huntington's Disease
- A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington’s Disease
- A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin.
- A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort
- A thiol probe for measuring unfolded protein load and proteostasis in cells
- A two years longitudinal study of a transgenic Huntington disease monkey
- Adenovirus vector based in vitro neuronal cell model for Huntington's Disease with human disease-like differential aggregation and degeneration
- Aggregation-Prone Proteins Modulate Huntingtin Inclusion Body Formation in Yeast
- Altered brain mechanisms of emotion processing in pre-manifest Huntington’s disease
- Altered Hypothalamic Protein Expression in a Rat Model of Huntington's Disease
- An N-terminal nuclear export signal regulates trafficking and aggregation of Htt exon 1
- Are Long-Range Structural Correlations Behind the Aggregration Phenomena of Polyglutamine Diseases?
- Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells
- Attenuation of Rhes Activity Significantly Delays the Appearance of Behavioral Symptoms in a Mouse Model of Huntington's Disease
- Biomarkers for Huntington’s Disease
- Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HdhQ150 knock-in mouse model of Huntington’s disease
- Cerebellar Soluble Mutant Ataxin-3 Level Decreases during Disease Progression in Spinocerebellar Ataxia Type 3 Mice
- Cerebrospinal fluid–based kinetic biomarkers of axonal transport in monitoring neurodegeneration
- Characterization of a Large Group of Individuals with Huntington Disease and Their Relatives Enrolled in the COHORT Study
- Characterization of forebrain neurons derived from late-onset Huntington's disease human embryonic stem cell lines
- Characterization of Striatal Neuronal Loss and Atrophy in the R6/2 Mouse Model of Huntington’s Disease
- Comprehensive treatment of Huntington disease and other choreic disorders
- Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease
Plugin by dagondesign.com
